For the Inventor, By the Inventor

Enter assignee name

Belleville, Canada

Bioniche Life Sciences Inc.

USPTO Granted Patents = 18

EPO Patents = 4

Trademarks = 9

Forward Citations = 107

Loading Chart...

Loading Chart...

15 inventors (with patents filed for the assignee):

Nigel C Phillips (14 out of 19 patents)

Mario C Filion (14 out of 18 patents)

Stéphanie Reader (4 out of 5 patents)

4. Zdenek Richard Holan (3 out of 7 patents)

5. John Douglas Baker (2 out of 3 patents)

6. John Thor Arnason (2 out of 8 patents)

7. Stanley J Alkemade (2 out of 10 patents)

8. Calum McRae (2 out of 2 patents)

9. Jose M Wade (2 out of 2 patents)

10. Phillippe Riviere (1 out of 1 patent)

11. Marc Riviere (1 out of 1 patent)

12. Andrea C Herréra Gayol (1 out of 1 patent)

13. Bruce J Nosky (1 out of 1 patent)

14. Robert E Pitts (1 out of 1 patent)

15. Dragan R Rogan (1 out of 2 patents)

18 patents: Sort by Forward Citations

1. 8350016 - Oligonucleotide compositions and their use to induce apoptosis (2013-01-08),

2. 8293745 - Use of imatinib to treat liver disorders and viral infections (2012-10-23),

3. 7985432 - Insect repellent (2011-07-26),

4. 7893242 - Oligonucleotide compositions and their use to induce apoptosis (2011-02-22),

5. 7662792 - Modulation of Fas and FasL expression (2010-02-16),

6. 7635686 - Therapeutically useful triethyleneglycol cholesteryl oligonucleotides (2009-12-22),

7. 7381431 - Insect repellent (2008-06-03),

8. 7371734 - Oligonucleotide compositions and their use for the modulation of immune responses (2008-05-13),

9. 7199228 - Oligonucleotide compositions and their use to induce apoptosis (2007-04-03),

10. 7157436 - Therapeutically useful synthetic oligonucleotides (2007-01-02),

11. 7125858 - Hyaluronic acid in the treatment of cancer (2006-10-24),

12. 7087586 - Oligonucleotide compositions and their use to induce differentiation of cells (2006-08-08),

13. 6890911 - Method for the treatment of inflammation (2005-05-10),

14. 6890541 - Method for enhancing production performance in an animal (2005-05-10),

15. 6809081 - Chemotherapeutic composition and method (2004-10-26),

Bioniche Life Sciences Inc. is a biopharmaceutical company focused on the development, manufacturing, and commercialization of innovative healthcare products. With a strong emphasis on research and development, Bioniche aims to provide solutions for unmet medical needs in the fields of oncology, urology, and vaccines. Their dedicated team works towards improving patient outcomes and enhancing quality of life through their cutting-edge therapeutics and expertise in bio-therapeutics, immunotherapy, and drug delivery systems.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

18 Patents

#1 in Belleville

#777 in Canada

#33,166 in the World

Belleville, Canada

Bioniche Life Sciences Inc.

Forward Citations = 107

15 inventors:

Nigel C Phillips (14 out of 19 patents)

Mario C Filion (14 out of 18 patents)

Stéphanie Reader (4 out of 5 patents)

4. Zdenek Richard Holan (3 out of 7 patents)

5. John Douglas Baker (2 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…